Researchers have determined that two Phase 1 drugs (CX-4945 and JQ1) can work together to efficiently kill T-cell acute lymphoblastic leukemia cells while having minimal impact on normal blood cells, representing a significant advancement in T-Cell Leukemia Treatment. Although both drugs…
A New Approach to Fighting Leukemia
Chronic myeloid leukemia develops when a gene mutates, causing blood-forming stem cells to grow rapidly into abnormal cells, known as leukemic tumors. The enzyme, Abl-kinase, is a member of the “kinase” family of enzymes, which serve as an “on” or “off”…